| Literature DB >> 25482414 |
Eléonore C Michel1, Vanessa Montaño-Machado, Pascale Chevallier, Amélie Labbé-Barrère, Didier Letourneur, Diego Mantovani.
Abstract
The modification of biomaterial surfaces with biomolecules influences the biological response. In this work, caboxymethyldextrans (Entities:
Keywords: anti-thrombogenic property; carboxymethyldextran; dextran coatings; endothelial cells; smooth muscle cells; surface immobilization
Mesh:
Substances:
Year: 2014 PMID: 25482414 PMCID: PMC4122567 DOI: 10.4161/biom.28805
Source DB: PubMed Journal: Biomatter ISSN: 2159-2527

Figure 1.1H-NMR spectra of: (A) dextran T70; (B) CMD 0.2; (C) CMD 0.4; (D) CMD 1.3. H1 peak represents the anomeric proton, H2-H6 (dash line) are the remaining protons of the anhydroglycopyranoside unit of dextran. H1’ is the anomeric proton when the position 2 is substituted. a (plain line) peaks represent the protons of carboxymethyl groups.
Table 1. Degree of substitution assessed by 1H-NMR and acid-base titration method. Dx/MCA is the molar ratio of dextran on monochloroacetic acid used for each synthesis
| CMD | Ratio Dx/MCA [mol/mol] | Degree of substitution | |
|---|---|---|---|
| 1H-NMR | Titration | ||
| CMD 0.2 | 1.0 | 0.17 | 0.18 ± 0.02 |
| CMD 0.4 | 2.5 | 0.37 | 0.43 ± 0.01 |
| CMD 1.3 | 2.5* | 1.32 | 1.19 ± 0.05 |
Dx/MCA value for each of the carboxymethylation step which was done two times in this case.
Table 2. Surface chemical composition obtained from XPS survey spectra for PTFE before and after plasma treatment and CMDs grafting
| C (%) | F (%) | N (%) | O (%) | O/F | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 33.3 | 66.6 | - | - | - | ||||||
| 49.6±1.0 | 40.9±2.1 | 6.7±0.7 | 2.1±0.5 | 0.05±0.01 | ||||||
| 49.8±2.4 | 31.7±4.2 | 2.2±0.5 | 13.5±1.7 | 0.44±0.11 | ||||||
| 49.9±3.7 | 32.7±5.8 | 1.9±0.5 | 14.6±2.8 | 0.47±0.19 | ||||||
| 52.1±2.6 | 31.1±3.0 | 3.9±0.7 | 11.4±1.7 | 0.37±0.08 |
Some contaminations were detected: Cl less than 1.0% and Na less than 1.6% at the maximum.
Figure 2. Contact angle measurements with water on bare PTFE and modified with CMDs. PTFE: 120.9° ± 3.7°; CMD 0.2: 37.1° ± 4.2° ; CMD 0.4: 32.7° ± 5.0° ; CMD1.3: 41.2° ± 9.7°. n > 5.

Figure 3. Relative percentage from XPS high resolution on C1s with the following bonds: CF2 (291.5eV); NC=O/HOC=O (288.5eV); C-N/C-O (286.5eV) and C-C/C-H (285.0eV). n = 3.

Figure 4. Clotting time evaluation by free-hemoglobin absorbance measurement. *Indicates the values significantly different from PTFE for each time determined by ANOVA one-way P < 0.05.

Figure 7. Suggested CMD 0.2 and CMD 1.3 coatings topography depending on the environment.

Figure 5. HUVEC and HUASMC adhesion on CMD grafted PTFE surface and bare PTFE. * and ** indicates the values significantly different respectively from PTFE and all other samples, determined by one way ANOVA P < 0.05. n = 3.
. Adhesion tests with endothelial cells. (A) uncoated PTFE; (B) CMD 0.2; (C) CMD 0.4; (D) CMD 1.3.